Emerson Q2 sales rise 3% to $4.56 billion; adjusted EPS $1.54 vs $1.48
Emerson reported fiscal second-quarter 2026 results for the quarter ended March 31, 2026, with net sales up 3% to $4,562 million and GAAP earnings per share up 28% to $1.10, while underlying sales grew only 0.5% and adjusted segment EBITA margin slipped to 27.6%. The company also updated its full-year 2026 outlook, now calling for adjusted EPS of $6.45 to $6.55, and separately said its board elected Jennifer Newstead as a director effective August 3, 2026.
Key points
- Net sales $4,562 million vs $4,432 million a year earlier; underlying sales up 0.5%; underlying orders up 5%.
- GAAP EPS $1.10 vs $0.86; adjusted EPS $1.54 vs $1.48; adjusted segment EBITA margin 27.6% vs 28.0%.
- Operating cash flow $779 million vs $825 million; free cash flow $694 million vs $738 million.
- FY2026 outlook: adjusted EPS $6.45 to $6.55, net sales growth about 4.5%, underlying sales growth about 3%; plans of about $2.2 billion in shareholder returns, including about $1 billion in buybacks.
The filing
Written by AI (Anthropic Claude, claude-haiku-5-5) on Nov 8, 2026, 1:21 AM ET, from the text of the filing and its press-release exhibits only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on May 05, 2026.
Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.